| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |